ANI Pharmaceuticals Inc expected to post earnings of $1.42 a share - Earnings Preview

ANI Pharmaceuticals

06/08/2025 13:45

ANI Pharmaceuticals Inc ANIP.OQ ANIP.O is expected to  show a rise in quarterly revenue when it reports  results on August 8 for the period ending June 30 2025

The Baudette Minnesota-based  company is expected to report a 37.8% increase in revenue to $190.288 million from $138.04 million a year ago, according to the mean estimate from 8 analysts, based on LSEG data.

​LSEG's mean analyst estimate for ANI Pharmaceuticals Inc is for earnings of $1.42 per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for ANI Pharmaceuticals Inc is $84.00, about 21.6% above its last closing price of $65.87

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
1.40
1.38
1.70
Beat
23
Dec. 31 2025
1.43
1.44
1.63
Beat
13.6
Sep. 30 2024
1.08
1.09
1.34
Beat
23.4​
Jun. 30 2024
0.96
0.95
1.02
Beat
7.4
​​Mar. 31 2024
1.00
1.00
1.21
Beat
21.5
Dec. 31 2023
0.87
0.86
1.00
Beat
17​
Sep. 30 2023
0.85
0.84
1.27
Beat
50.6
Jun. 30 2023
0.67
0.68
1.28
Beat
88.9

This summary was machine generated August 6 at 12:45 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)